Showing results (111-120 of 161) with videos related to
Sort By:
Pageof 17
Progress in Clinical and Biological Research|January 1, 1986
Experimental models of bladder cancer: a critical reviewD Raghavan, F Debruyne, H Herr, et al.Australian and New Zealand Journal of Medicine|December 1, 1983
The role of hepatitis B virus in the etiology of hepatocellular carcinoma in AustraliaA G Dalgleish, R L Woods, J A Levi, et al.The British Journal of Cancer. Supplement|April 1, 1980
The interpretation of marker protein assays: a critical appraisal in clinical studies and a xenograft modelD Raghavan, J Gibbs, R Nogueira Costa, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1994
Multiple atypical nevi: a cutaneous marker of germ cell tumorsD Raghavan, J R Zalcberg, J J Grygiel, et al.British Journal of Urology|April 1, 1987
Aminoglutethimide in advanced prostatic carcinomaP R Harnett, D Raghavan, I Caterson, et al.The Prostate|January 1, 1989
Site-specific growth of the prostate xenograft line UCRU-PR-2M E Jelbart, P J Russell, P Russell, et al.British Journal of Urology|May 1, 1992
Phase II clinical trial of recombinant alpha-2 interferon for biopsy-proven metastatic or recurrent renal carcinomaM A Rosenthal, K Cox, D Raghavan, et al.Seminars in Oncology|February 1, 1992
Carboplatin-containing regimens for small cell lung cancer: implications for management in the elderlyD Raghavan, J F Bishop, R Stuart-Harris, et al.Investigational New Drugs|January 1, 1997
Unusual central nervous system toxicity in a phase I study of N1N11 diethylnorspermine in patients with advanced malignancyP J Creaven, R Perez, L Pendyala, et al.Seminars in Oncology|December 1, 1996
Early phase studies with paclitaxel/low-dose carboplatin in patients with solid tumorsP J Creaven, D Raghavan, R P Perez, et al.Pageof 17